Arley Peter
University of Miami
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Arley Peter.
Circulation | 2004
Alexandre Ferreira; Arley Peter; Armando J. Mendez; Joaquin J. Jimenez; Lucia M. Mauro; Julio A. Chirinos; Reyan Ghany; Salim S. Virani; Santiago Garcia; Lawrence L. Horstman; Joshua Purow; Wenche Jy; Yeon S. Ahn; Eduardo de Marchena
Background—This study evaluated a possible relationship between levels of endothelial microparticles (EMPs), known to be a sensitive indicator of endothelial disturbance, and changes in postprandial lipid levels in healthy volunteers after a low- or high-fat meal. Methods and Results—Eighteen healthy subjects without known cardiovascular risk factors were evaluated. Lipid and EMP levels were measured before and 1 and 3 hours after a single low- or high-fat isocaloric meal. The low-fat meal had no significant postprandial effect on EMPs or lipids compared with fasting levels. In contrast, a single high-fat meal significantly increased EMP levels after 1 and 3 hours, from 389±54 (thousands per milliliter) when fasting to 541±139 (P=0.0002) and 677±159 (P<0.0001), respectively, and correlated with a postprandial elevation in serum triglycerides. Conclusions—A single high-fat meal led to a significant elevation of plasma EMP levels in healthy, normolipidemic subjects and correlated with a postprandial elevation of serum triglycerides. EMPs may be an indirect marker of endothelial dysfunction or injury induced by postprandial triglyceride-rich lipoproteins.
The Annals of Thoracic Surgery | 2003
Alexandre Ferreira; Arley Peter; Tomas A. Salerno; Hooshang Bolooki; Eduardo de Marchena
BACKGROUND The long-term benefits of angioplasty are limited by the occurrence of restenosis. Drug-eluting stents with a projected restenosis rate of close to 0% are soon to become available. The short- and long-term consequences of this advance to the cardiac surgical volume remain unclear. METHODS A total of 196 consecutive coronary angiograms and medical records of patients referred for coronary bypass surgery were reviewed. Considering the hypothetical premise of having drug-eluting stents with a near zero restenosis rate, we reviewed each case to determine if surgical revascularization was still the preferred option for revascularization. RESULTS The mean age was 60 (+/-10.6) years. Seventy-two percent of patients were male. Considering the availability of drug-eluting stents 154 (79%) would still have been sent to surgery, representing a 21% decrease in the number of surgical revascularizations. Angiographic characteristics predicting coronary bypass revascularization were the presence of chronic total occlusion (odds ratio [OR]: 9.1; confidence interval [CI]: 2.1 to 39), left main coronary artery stenosis (OR: 9.6; CI: 1.27 to 73), and need for valvular surgery (OR: 7.38; CI: 1.3 to 157). The most common predictors of a change in clinical management from surgical to percutaneous revascularization if drug-eluting stents were available were diffuse coronary narrowing (OR: 15.78), restenotic lesions (OR: 27.86), and small coronary arteries (OR: 26). CONCLUSIONS Drug-eluting stents may have a significant impact on cardiac surgery volume (approximately a 21% decrease in our center). It may also direct patients with small vessels, diffuse narrowing, or restenotic lesions and diabetic patients to percutaneous therapy.
Arquivos Brasileiros De Cardiologia | 2004
Alexandre Ferreira; Arley Peter; Simon Chakko; Howard J. Willens; Eduardo de Marchena
We report a patient with profound hypovolemia who developed dynamic left ventricular outflow tract obstruction and severe mitral regurgitation. Both the outflow tract obstruction and mitral regurgitation resolved with volume replacement. Unlike previous reports of dynamic left ventricular outflow obstruction and mitral regurgitation, the degree of mitral regurgitation was severe. Possible mechanisms are discussed.
American Journal of Cardiology | 2004
Santiago Garcia; Mariana Canoniero; Arley Peter; Eduardo de Marchena; Alexandre Ferreira
International Journal of Cardiology | 2006
Arley Peter; Alexandre Ferreira; Kenneth Zelnick; Afolabi Sangosanya; Julio A. Chirinos; Eduardo de Marchena
Heart Disease | 2003
Alexandre Ferreira; Santiago Garcia; Melissa A. Pasquale; Mariana Canoniero; Arley Peter
Texas Heart Institute Journal | 2005
Dalton Miranda; Arley Peter; Jose Osorio; Alexandre Ferreira
Chest | 2006
Julio A. Chirinos; Eduardo de Marchena; Anila Veerani; Arley Peter; Nasser Khan; Alan Schob; Alex Ferreira; Simon Chakko
Chest | 2006
Julio A. Chirinos; Eduardo de Marchena; Alex Ferreira; Carlos Alfonso; Anila Veerani; Arley Peter; Rene Parraga; Wenche Jy; Joaquin J. Jimenez; Lawrence L. Horstman; Yeon S. Ahn
Society of Nuclear Medicine Annual Meeting Abstracts | 2007
Warren R. Janowitz; Jack A. Ziffer; Arley Peter; Mehul Bhatt; Jose Osorio; Hao Vuong; Larry Elgaresta